Imaging of neuroendocrine tumors

Seminars in Oncology

Volumn 40, Issue 1, 2013, Pages 109-119

  Leung, David ^a   Schwartz, Lawrence ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; HYDROCARBON; KI 67 ANTIGEN; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR 2; SULFUR HEXAFLUORIDE;

ARTICLE; CANCER PROGNOSIS; CELL MEMBRANE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; HUMAN; IMAGE QUALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROENDOCRINE TUMORS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84873377513     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.11.008     Document Type: Article

References (43)

1. S. Philips, S.N. Shah, R. Vikram et al. Pancreatic endocrine neoplasms: a current update on genetics and imaging Br J Radiol 85 2012 682 696
2. M. Luster et al. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma Eur J Nucl Med Mol Imaging 37 Mar, 2010 484
3. H. Gouya et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas AJR Am J Roentgenol 181 Oct, 2003 987
4. N.J. Owen et al. MRI of pancreatic neuroendocrine tumours Br J Radiol 74 Oct, 2001 74
5. R.F. Thoeni, U.G. Mueller-Lisse, R. Chan, N.K. Do, P.B. Shyn Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity Radiology 214 Feb, 2000 483
6. P.C. Buetow et al. Islet cell tumors of the pancreas: Pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status American Journal of Roentgenology 165 1995 1175
7. K.M. Horton, R.H. Hruban, C. Yeo, E.K. Fishman Multi-detector row CT of pancreatic islet cell tumors Radiographics 26 Mar-Apr, 2006 453
8. J.L. Fidler et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT AJR Am J Roentgenol 181 Sep, 2003 775
9. P.T. Johnson, K.M. Horton, E.K. Fishman Nonvascular Mesenteric Disease: Utility of Multidetector CT with 3D Volume Rendering1 Radiographics 29 May-June 2009 721 2009
10. A.G. Rockall, R.H. Reznek Imaging of neuroendocrine tumours (CT/MR/US) Best Pract Res Cl En 21 Mar, 2007 43
11. S. Bonekamp, C.P. Corona-Villalobos, I.R. Kamel Oncologic applications of diffusion-weighted MRI in the body J Magn Reson Imaging 35 Feb, 2012 257
12. A. Goyal et al. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype Acta Radiol 53 Apr 1, 2012 349
13. A.A. Malayeri et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up Radiographics 31 Oct, 2011 1773
14. D.M. Koh, D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 Jun, 2007 1622
15. Y. Wang et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics J Magn Reson Imaging 33 May, 2011 1071
16. M.A. Anderson et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas Am J Gastroenterol 95 Sep, 2000 2271
17. S.R. Wilson, L.D. Greenbaum, B.B. Goldberg Contrast-Enhanced Ultrasound: What Is the Evidence and What Are the Obstacles? American Journal of Roentgenology 193 July 1, 2009 55 2009
18. S. Rickes, K. Unkrodt, K. Ocran, H. Neye, W. Wermke Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy Pancreas 26 Jan, 2003 76
19. T. Bartolotta, A. Taibbi, M. Midiri, R. Lagalla Focal liver lesions: contrast-enhanced ultrasound Abdominal Imaging 34 2009 193
20. S. Jonas et al. Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues Langenbeck Arch Chir 380 1995 90
21. K.E. Oberg, J.Ä. Reubi, D.J. Kwekkeboom, E.P. Krenning Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy Gastroenterology 139 2010 742
22. G. Kloppel et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification (vol 90, pg 162, 2009) Neuroendocrinology 90 2009 432
23. E.P. Krenning, D.J. Kwekkeboom, S. Pauwels, L.K. Kvols, J.C. Reubi L.M. Freedman, Nuclear Medicine Annual 1995 Lippincott Williams & Wilkins New York 1 50
24. D.L. Bushnell, R.P. Baum Standard Imaging Techniques for Neuroendocrine Tumors Endocrin Metab Clin 40 Mar, 2011 40
25. A.J. van der Lely, W.W. de Herder, E.P. Krenning, D.J. Kwekkeboom Octreoscan radioreceptor imaging Endocrine 20 Apr, 2003 307
26. J.J. Teunissen, D.J. Kwekkeboom, R. Valkema, E.P. Krenning Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours Endocr Relat Cancer 18 Suppl 1 Oct, 2011 S27
27. J. Ruf et al. 68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol Journal of nuclear medicine: official publication, Society of Nuclear Medicine 52 May, 2011 697
28. M. de Jong et al. Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings Semin Nucl Med 32 Apr, 2002 133
29. B. Eriksson New drugs in neuroendocrine tumors: rising of new therapeutic philosophies? Curr Opin Oncol 22 Jul, 2010 381
30. M. de Jong, W.A.P. Breeman, D.J. Kwekkeboom, R. Valkema, E.P. Kenning Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues Accounts of Chemical Research 42 2009 783
31. C.A. Hoefnagel, F.C. den Hartog Jager, B.G. Taal, N.G. Abeling, E.E. Engelsman The role of I-131-MIBG in the diagnosis and therapy of carcinoids Eur J Nucl Med 13 1987 187
32. I.M. Modlin Gastrointestinal carcinoids: The evolution of diagnostic strategies J Clin Gastroenterol 40 Aug, 2006 572
33. I.M. Modlin, M. Kidd, I. Latich, M.N. Zikusoka, M.D. Shapiro Current status of gastrointestinal carcinoids Gastroenterology 128 May, 2005 1717
34. T. Binderup Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, (123)I-MIBG Scintigraphy, and (18)F-FDG PET J Nucl Med 51 May 1, 2010 704
35. T. Binderup, U. Knigge, A. Loft, B. Federspiel, A. Kjaer 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors Clinical Cancer Research 16 February 1, 2010 978
36. J.R. Bading, A.F. Shields Imaging of cell proliferation: status and prospects Journal of nuclear medicine: official publication, Society of Nuclear Medicine 49 Suppl 2 Jun, 2008 64S
37. F. Giammarile et al. 18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours Nucl Med Commun 32 Feb, 2011 91
38. K. Oberg, D. Castellano Current knowledge on diagnosis and staging of neuroendocrine tumors Cancer Metastasis Rev 30 Suppl 1 Mar, 2011 3
39. M. Hofmann Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data Eur J Nucl Med 28 Dec, 2001 1751
40. D. Wild et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5 Eur J Nucl Med Mol Imaging 32 Jun, 2005 724
41. 111In-DTPA-Octreotide (OctreoScan®) Molecular Imaging and Biology 13 2011 583
42. K.P. Koopmans Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-Alanine and 11C-5-hydroxy-tryptophan positron emission tomography J Clin Oncol 26 Mar 20, 2008 1489
43. J.K. Ramage et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) Gut 61 Jan, 2012 6